Semax 11mg
Semax is supplied strictly as a laboratory research material for analytical and scientific use only. Available to qualified researchers, laboratories, and institutions in Perth and across Western Australia, with Australian-based fulfilment.
Intended for in‑vitro research, assay development, method validation, and controlled scientific investigation by appropriately qualified professionals.
Product details
-
Product: Semax
-
Sequence: H-Met-Glu-His-Phe-Pro-Gly-Pro-OH.
-
Strength / size: 11 Mg
-
Category: Research compound / research peptide
-
Form: Lyophilised powder
-
Use: Laboratory research only
-
Supply: Perth & Western Australia (AU shipping)
Semax (ACTH(4–10) Pro-Gly-Pro) is a synthetic heptapeptide derived from a fragment of Adrenocorticotropic hormone(ACTH). It was originally developed in Russia and has been studied for its potential neuroprotective and cognitive-enhancing properties.
Unlike traditional stimulants, Semax does not act as a direct dopamine or norepinephrine agonist. Instead, it appears to work at a regulatory level within the central nervous system. One of its most studied mechanisms is the upregulation of Brain-derived neurotrophic factor (BDNF), a neurotrophin essential for neuronal survival, synaptic plasticity, and memory formation. Increased BDNF expression is associated with enhanced learning capacity and improved resilience to neurological stress.
Semax is also notable for its ability to cross the blood–brain barrier, allowing it to exert direct central effects. Preclinical studies have demonstrated improvements in memory consolidation, attention, and cognitive performance under stress conditions. In addition, experimental models suggest it may reduce oxidative stress and apoptosis, supporting its classification as a neuroprotective agent.
Clinically, Semax has been used in Russia for conditions such as ischemic stroke, optic nerve disorders, and certain cognitive impairments. Some studies report improved neurological recovery following stroke, though most available research consists of animal studies or small human trials.
While current evidence suggests meaningful neurotrophic and neuroprotective activity, larger controlled human studies are needed to fully establish its efficacy and long-term safety profile. Nonetheless, Semax remains an intriguing compound in the field of cognitive modulation and neuroregenerative research.
